Step away from the blinders that partisan politics uses to distract, divide and conquer, and you will find that we are drowning in a cesspool of problems that individually and collectively threaten our lives, liberties, prosperity and happiness.
Tag: United States
Post
THE CHINESE SPY BALLOON HOAX
After the Russiagate Hoax, the Covid hoax, and the Insurrection hoax, We now Have the Chinese Spy Balloon Hoax.
Post
A TALE OF THREE CITIES
One might actually be willing to consider that there might be some value in the “rules based international order” being promoted by the Joe Biden Administration if such a thing actually existed and was applied equally to all transgressors.
Post
LAST WEEK: STOCKS RALLY ON INFLATION NEWS, INTEREST RATE HOPES
U.S. equity markets slipped Friday on news that the economy added 517,000 jobs in January, raising concerns that the U.S. Federal Reserve might keep interest rates higher longer.
Post
SPOTLIGHT: BIGS GETTING BIGGER
As forecast, the Merger and Acquisition trend which we have been long reporting would peak when the Federal Reserve would aggressively raise interest rates and cut off the cheap money supply.
Post
CRITICAL WOKE THEORY FOR DUMMIES
As we enter the new year, America has passed far beyond the threshold when the public needs to put ideological beliefs and partisan politics aside and honestly reevaluate how our culture has become a toxic stew of maladaptive groupthink.
Post
CLOSE ENCOUNTERS RISING? PENTAGON SAYS IT’S TRUE
You’re not just seeing things. U.S. spy agencies and the Pentagon said in a report this past week that UFO (Unidentified Aerial Phenomena) sightings have surged over the past two years. And authorities have no easy explanation as to why, according to The Wall Street Journal.
Post
ECONOMIC UPDATE – MARKET OVERVIEW
All economic eyes this week are on Davos, and according to The Wall Street Journal, the “Mood is Somber as Many CEOs Question Economy’s Future.”
Post
SPOTLIGHT: BIGS GETTING BIGGER
U.S. biotech giant Amgen has bought Horizon Therapeutics, a maker of drugs that treat rare autoimmune and inflammatory illnesses, for $28.3 billion, Amgen’s priciest purchase to date.